CVE-2025-36039

CVE-2025-36039 is a medium-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-602.

Key facts

Description

IBM Aspera Faspex 5.0.0 through 5.0.12.1 could allow an authenticated user to perform unauthorized actions due to client-side enforcement of sever side security mechanisms,

Frequently asked questions

What is CVE-2025-36039?
IBM Aspera Faspex 5.0.0 through 5.0.12.1 could allow an authenticated user to perform unauthorized actions due to client-side enforcement of sever side security mechanisms,
How severe is CVE-2025-36039?
CVE-2025-36039 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2025-36039 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (17th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-36039?
CVE-2025-36039 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-36039?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-36039 have an EU (EUVD) identifier?
Yes. CVE-2025-36039 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-23213.
When was CVE-2025-36039 published?
CVE-2025-36039 was published on 2025-07-31 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Aspera Faspex

All CVEs affecting Ibm Aspera Faspex →

Other CWE-602 vulnerabilities

Browse all CWE-602 vulnerabilities →